vlx600
Small moleculeexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2014 (NCT02222363)
Timeline
2010s
- Jan 1, 2014
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Hypoxia-inducible factor 1-alphaACTIVATOR
HIF1A activator
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- vlx600
- vlx600
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02222363 | Phase 1 | Aug 1, 2014 | Mayo Clinic, Theradex, Vivolux AB |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Mayo Clinic | Academic/Hospital | 1 | 0 | 1 | 2014 |
| Theradex | For profit | 1 | 0 | 1 | 2014 |
| Vivolux AB | For profit | 1 | 1 | 1 | 2014 |
3 organizations
Page 1 / 1